Skip to content

Zenas BioPharma

US · ZBIO #2856 by market cap Listed 2024
23.85 -1.19 -4.75%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    Analysts Offer Insights on Healthcare Companies: Zenas BioPharma, Inc. (ZBIO) and Atai Beckley N.V. (ATAI)
    TipRanks · 2026/6/27
  • Rating change
    Guggenheim Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/8/14
  • Rating change
    Morgan Stanley Maintains Zenas BioPharma(ZBIO.US) With Hold Rating, Raises Target Price to $32
    Market Newswire · 2026/8/17
  • Rating change
    Wedbush Keeps Their Buy Rating on Zenas BioPharma, Inc. (ZBIO)
    TipRanks · 2026/8/14
  • Rating change
    Citi Sticks to Its Buy Rating for Zenas BioPharma, Inc. (ZBIO)
    TipRanks · 2026/9/11
  • Morgan Stanley Maintains Zenas BioPharma(ZBIO.US) With Hold Rating, Maintains Target Price $32
    Market Newswire · 2026/11/6
  • Rating change
    Morgan Stanley Reaffirms Their Hold Rating on Zenas BioPharma, Inc. (ZBIO)
    TipRanks · 2026/8/14
  • Rating change
    Analysts Are Bullish on Top Healthcare Stocks: Zenas BioPharma, Inc. (ZBIO), Ocular Therapeutix (OCUL)
    TipRanks · 2026/10/13
  • Rating change
    Citi Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $41
    Market Newswire · 2026/9/11
  • Rating change
    Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)
    TipRanks · 2026/8/14
  • Morgan Stanley Initiates Zenas BioPharma(ZBIO.US) With Hold Rating, Announces Target Price $32
    Market Newswire · 2026/10/28
  • Rating change
    H.C. Wainwright Keeps Their Buy Rating on Zenas BioPharma, Inc. (ZBIO)
    TipRanks · 2026/9/22
  • Rating change
    Wedbush Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/8/14
  • Earnings Flash (ZBIO) Zenas BioPharma, Inc. Reports Q3 Revenue $10.0M
    MT Newswires · 2026/11/5
  • Rating change
    Analysts Are Bullish on Top Healthcare Stocks: DocGo (DCGO), Zenas BioPharma, Inc. (ZBIO)
    TipRanks · 2026/9/30
  • H.C. Wainwright Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $44
    Market Newswire · 2026/11/9
  • Rating change
    Wedbush Remains a Buy on Zenas BioPharma, Inc. (ZBIO)
    TipRanks · 2026/10/13
  • Citi Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/10/28
  • Rating change
    Zenas BioPharma, Inc. (ZBIO) Receives a Buy From Guggenheim
    TipRanks · 2026/8/14
  • Rating change
    Citi Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Raises Target Price to $48
    Market Newswire · 2026/9/30
  • Rating change
    Analysts' Top Healthcare Picks: Zenas BioPharma, Inc. (ZBIO), Entrada Therapeutics Inc (TRDA)
    TipRanks · 2026/6/3
  • Rating change
    Analysts Are Bullish on Top Healthcare Stocks: Alpha Cognition Inc (ACOG), Zenas BioPharma, Inc. (ZBIO)
    TipRanks · 2026/6/11
  • H.C. Wainwright Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $44
    Market Newswire · 2026/10/28
  • Citi Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/10/13
  • Rating change
    Wedbush Initiates Zenas BioPharma(ZBIO.US) With Buy Rating, Announces Target Price $45
    Market Newswire · 2026/5/14

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Zenas BioPharma discussion 0 comments

Add a comment